drugset / Trial / NCT06367855

Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF

NCT06367855 ↗

Phase 4 Recruiting 60 enrolled Potsawat Surabotsopon
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Researchers are considering Dexamethasone as preemptive medication before minimally invasive spine fusion surgery to minimize postoperative back pain with minimal side effects, aiming to enhance the effectiveness of surgery and improve patient outcomes.

Timeline

Start
2024-05-01
Primary completion
2025-11-30
Completion
2025-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule — Intravenous